Details for New Drug Application (NDA): 019963
✉ Email this page to a colleague
The generic ingredient in RENOVA is tretinoin. There are twenty-six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the tretinoin profile page.
Summary for 019963
Tradename: | RENOVA |
Applicant: | Valeant Pharms North |
Ingredient: | tretinoin |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 019963
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CREAM;TOPICAL | Strength | 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Dec 29, 1995 | TE: | RLD: | Yes |
Expired US Patents for NDA 019963
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Valeant Pharms North | RENOVA | tretinoin | CREAM;TOPICAL | 019963-001 | Dec 29, 1995 | ⤷ Sign Up | ⤷ Sign Up |
Valeant Pharms North | RENOVA | tretinoin | CREAM;TOPICAL | 019963-001 | Dec 29, 1995 | ⤷ Sign Up | ⤷ Sign Up |
Valeant Pharms North | RENOVA | tretinoin | CREAM;TOPICAL | 019963-001 | Dec 29, 1995 | ⤷ Sign Up | ⤷ Sign Up |
Valeant Pharms North | RENOVA | tretinoin | CREAM;TOPICAL | 019963-001 | Dec 29, 1995 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription